70842-101 : Baxdela 450 mg Oral Tablet
| NDC: | 70842-101 |
| Labeler: | Melinta Therapeutics, Inc |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Baxdela |
| Dosage Form: | Oral Tablet |
| Application #: | NDA208610 |
| Rev. Date: |
Appearance:
| Markings: | RX3341 |
| Shapes: |
Oval |
| Colors: |
 Brown |
| Size (mm): | 21 |
| Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. | |
NDC Package Codes:
- 70842-101-01: 1 BOTTLE IN 1 CARTON (70842‑101‑01) > 20 TABLET IN 1 BOTTLE
- 70842-101-02: 2 BLISTER PACK IN 1 CARTON (70842‑101‑02) > 10 TABLET IN 1 BLISTER PACK
- 70842-101-05: 1 BLISTER PACK IN 1 CARTON (70842‑101‑05) > 2 TABLET IN 1 BLISTER PACK
Active Ingredients:
- Delafloxacin Meglumine
Dosage Strength:
- 450 mg
Inactive Ingredients:
- Microcrystalline Cellulose
- Povidone K30
- Crospovidone (12 Mpa.s At 5%)
- Sodium Bicarbonate
- Sodium Phosphate, Monobasic, Unspecified Form
- Anhydrous Citric Acid
- Magnesium Palmitostearate
- Water
Pharmaceutical Classes:
- Fluoroquinolone Antibacterial [EPC]
- Fluoroquinolones [CS]
Related Products:
Based on records with the same trade name.- 70842-102 Baxdela 300 mg/10.5ml Intravenous Injection, Powder, Lyophilized, for Solution by Melinta Therapeutics, Inc
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 70841-0475Next: 70842-102 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.